753 related articles for article (PubMed ID: 25337873)
1. Cessation of CCL2 inhibition accelerates breast cancer metastasis by promoting angiogenesis.
Bonapace L; Coissieux MM; Wyckoff J; Mertz KD; Varga Z; Junt T; Bentires-Alj M
Nature; 2014 Nov; 515(7525):130-3. PubMed ID: 25337873
[TBL] [Abstract][Full Text] [Related]
2. CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis.
Qian BZ; Li J; Zhang H; Kitamura T; Zhang J; Campion LR; Kaiser EA; Snyder LA; Pollard JW
Nature; 2011 Jun; 475(7355):222-5. PubMed ID: 21654748
[TBL] [Abstract][Full Text] [Related]
3. Anti-CCL2: building a reservoir or opening the floodgates to metastasis?
Hitchcock JR; Watson CJ
Breast Cancer Res; 2015 May; 17(1):68. PubMed ID: 25990313
[TBL] [Abstract][Full Text] [Related]
4. Chemokine (C-C motif) ligand 2 engages CCR2+ stromal cells of monocytic origin to promote breast cancer metastasis to lung and bone.
Lu X; Kang Y
J Biol Chem; 2009 Oct; 284(42):29087-96. PubMed ID: 19720836
[TBL] [Abstract][Full Text] [Related]
5. The Yin/Yan of CCL2: a minor role in neutrophil anti-tumor activity in vitro but a major role on the outgrowth of metastatic breast cancer lesions in the lung in vivo.
Lavender N; Yang J; Chen SC; Sai J; Johnson CA; Owens P; Ayers GD; Richmond A
BMC Cancer; 2017 Jan; 17(1):88. PubMed ID: 28143493
[TBL] [Abstract][Full Text] [Related]
6. Lipopolysaccharide induces inflammation and facilitates lung metastasis in a breast cancer model via the prostaglandin E2-EP2 pathway.
Li S; Xu X; Jiang M; Bi Y; Xu J; Han M
Mol Med Rep; 2015 Jun; 11(6):4454-62. PubMed ID: 25625500
[TBL] [Abstract][Full Text] [Related]
7. Targeting of CCL2-CCR2-Glycosaminoglycan Axis Using a CCL2 Decoy Protein Attenuates Metastasis through Inhibition of Tumor Cell Seeding.
Roblek M; Strutzmann E; Zankl C; Adage T; Heikenwalder M; Atlic A; Weis R; Kungl A; Borsig L
Neoplasia; 2016 Jan; 18(1):49-59. PubMed ID: 26806351
[TBL] [Abstract][Full Text] [Related]
8. Chronic psychological stress promotes lung metastatic colonization of circulating breast cancer cells by decorating a pre-metastatic niche through activating β-adrenergic signaling.
Chen H; Liu D; Guo L; Cheng X; Guo N; Shi M
J Pathol; 2018 Jan; 244(1):49-60. PubMed ID: 28940209
[TBL] [Abstract][Full Text] [Related]
9. CCL2 Is a Vascular Permeability Factor Inducing CCR2-Dependent Endothelial Retraction during Lung Metastasis.
Roblek M; Protsyuk D; Becker PF; Stefanescu C; Gorzelanny C; Glaus Garzon JF; Knopfova L; Heikenwalder M; Luckow B; Schneider SW; Borsig L
Mol Cancer Res; 2019 Mar; 17(3):783-793. PubMed ID: 30552233
[TBL] [Abstract][Full Text] [Related]
10. Increased Antiangiogenic Effect by Blocking CCL2-dependent Macrophages in a Rodent Glioblastoma Model: Correlation Study with Dynamic Susceptibility Contrast Perfusion MRI.
Cho HR; Kumari N; Thi Vu H; Kim H; Park CK; Choi SH
Sci Rep; 2019 Jul; 9(1):11085. PubMed ID: 31366997
[TBL] [Abstract][Full Text] [Related]
11. Suppression of choroidal neovascularization and quantitative and qualitative inhibition of VEGF and CCL2 by heparin.
Tomida D; Nishiguchi KM; Kataoka K; Yasuma TR; Iwata E; Uetani R; Kachi S; Terasaki H
Invest Ophthalmol Vis Sci; 2011 May; 52(6):3193-9. PubMed ID: 21296829
[TBL] [Abstract][Full Text] [Related]
12. Monocyte chemoattractant protein-1/CCL2 produced by stromal cells promotes lung metastasis of 4T1 murine breast cancer cells.
Yoshimura T; Howard OM; Ito T; Kuwabara M; Matsukawa A; Chen K; Liu Y; Liu M; Oppenheim JJ; Wang JM
PLoS One; 2013; 8(3):e58791. PubMed ID: 23527025
[TBL] [Abstract][Full Text] [Related]
13. A Decade of Experience in Developing Preclinical Models of Advanced- or Early-Stage Spontaneous Metastasis to Study Antiangiogenic Drugs, Metronomic Chemotherapy, and the Tumor Microenvironment.
Kerbel RS
Cancer J; 2015; 21(4):274-83. PubMed ID: 26222079
[TBL] [Abstract][Full Text] [Related]
14. 6-shogaol, an active constituent of dietary ginger, impairs cancer development and lung metastasis by inhibiting the secretion of CC-chemokine ligand 2 (CCL2) in tumor-associated dendritic cells.
Hsu YL; Hung JY; Tsai YM; Tsai EM; Huang MS; Hou MF; Kuo PL
J Agric Food Chem; 2015 Feb; 63(6):1730-8. PubMed ID: 25621970
[TBL] [Abstract][Full Text] [Related]
15. Cucurbitacin B inhibits breast cancer metastasis and angiogenesis through VEGF-mediated suppression of FAK/MMP-9 signaling axis.
Sinha S; Khan S; Shukla S; Lakra AD; Kumar S; Das G; Maurya R; Meeran SM
Int J Biochem Cell Biol; 2016 Aug; 77(Pt A):41-56. PubMed ID: 27210504
[TBL] [Abstract][Full Text] [Related]
16. Estrogen promotes progression of hormone-dependent breast cancer through CCL2-CCR2 axis by upregulation of Twist via PI3K/AKT/NF-κB signaling.
Han R; Gu S; Zhang Y; Luo A; Jing X; Zhao L; Zhao X; Zhang L
Sci Rep; 2018 Jun; 8(1):9575. PubMed ID: 29934505
[TBL] [Abstract][Full Text] [Related]
17. CCL2/CCR2 Regulates the Tumor Microenvironment in HER-2/neu-Driven Mammary Carcinomas in Mice.
Chen X; Wang Y; Nelson D; Tian S; Mulvey E; Patel B; Conti I; Jaen J; Rollins BJ
PLoS One; 2016; 11(11):e0165595. PubMed ID: 27820834
[TBL] [Abstract][Full Text] [Related]
18. CCL2 conditionally determines CCL22-dependent Th2-accumulation during TGF-β-induced breast cancer progression.
Mandal PK; Biswas S; Mandal G; Purohit S; Gupta A; Majumdar Giri A; Roy Chowdhury S; Bhattacharyya A
Immunobiology; 2018 Feb; 223(2):151-161. PubMed ID: 29107385
[TBL] [Abstract][Full Text] [Related]
19. Multiple roles of chemokine (C-C motif) ligand 2 in promoting prostate cancer growth.
Zhang J; Lu Y; Pienta KJ
J Natl Cancer Inst; 2010 Apr; 102(8):522-8. PubMed ID: 20233997
[TBL] [Abstract][Full Text] [Related]
20. Inflammatory monocyte mobilization decreases patient survival in pancreatic cancer: a role for targeting the CCL2/CCR2 axis.
Sanford DE; Belt BA; Panni RZ; Mayer A; Deshpande AD; Carpenter D; Mitchem JB; Plambeck-Suess SM; Worley LA; Goetz BD; Wang-Gillam A; Eberlein TJ; Denardo DG; Goedegebuure SP; Linehan DC
Clin Cancer Res; 2013 Jul; 19(13):3404-15. PubMed ID: 23653148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
